Pages that link to "Q33866799"
Jump to navigation
Jump to search
The following pages link to Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer (Q33866799):
Displaying 50 items.
- Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications (Q26738678) (← links)
- Stromal Targets for Fluorescent-Guided Oncologic Surgery (Q26774497) (← links)
- In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor. (Q27342927) (← links)
- A current perspective on applications of macrocyclic-peptide-based high-affinity ligands (Q28072407) (← links)
- Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids (Q28076701) (← links)
- Validation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy (Q30413694) (← links)
- Antibody-based imaging of HER-2: moving into the clinic. (Q30423880) (← links)
- Nanobody: the "magic bullet" for molecular imaging? (Q30442626) (← links)
- Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer (Q33681168) (← links)
- Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody (Q33686807) (← links)
- Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling (Q34148890) (← links)
- Generation of a nanobody targeting the paraflagellar rod protein of trypanosomes (Q34796514) (← links)
- Recent trends in antibody-based oncologic imaging (Q35643425) (← links)
- Peptides in headlock--a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy (Q35899535) (← links)
- Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody (Q36552076) (← links)
- Effects of attenuation map accuracy on attenuation-corrected micro-SPECT images (Q36630810) (← links)
- Molecular imaging probes for diagnosis and therapy evaluation of breast cancer (Q36692448) (← links)
- Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2 Breast Cancer Therapy. (Q36829233) (← links)
- Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle. (Q37085052) (← links)
- Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo (Q37226145) (← links)
- Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions (Q37569289) (← links)
- Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding (Q37655890) (← links)
- Review: Receptor Targeted Nuclear Imaging of Breast Cancer. (Q37690662) (← links)
- Biotechnological applications of recombinant single-domain antibody fragments (Q37887077) (← links)
- Immuno-imaging using nanobodies (Q37897404) (← links)
- Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer (Q38088005) (← links)
- Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target (Q38106992) (← links)
- Design and evaluation of radiolabeled tracers for tumor imaging (Q38137253) (← links)
- Imaging EGFR and HER2 by PET and SPECT: a review (Q38137829) (← links)
- Radiolabeling strategies for tumor-targeting proteinaceous drugs (Q38189541) (← links)
- Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer (Q38230884) (← links)
- Nanobody-based cancer therapy of solid tumors (Q38322471) (← links)
- Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers (Q38836740) (← links)
- Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection (Q38880847) (← links)
- Minimalist Antibodies and Mimetics: An Update and Recent Applications (Q38914281) (← links)
- Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. (Q39218666) (← links)
- Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells (Q39375321) (← links)
- Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators (Q39376122) (← links)
- Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities. (Q39793253) (← links)
- Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using (99m)Tc-Modified Nanobodies and SPECT/CT. (Q39808570) (← links)
- Alternative reagents to antibodies in imaging applications (Q41579389) (← links)
- Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies (Q42682314) (← links)
- Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery (Q45722014) (← links)
- Single Domain Antibodies as New Biomarker Detectors. (Q47099886) (← links)
- Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy (Q47121798) (← links)
- Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers. (Q47134203) (← links)
- A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells. (Q47150050) (← links)
- Expression of single-domain antibody in different systems (Q47312316) (← links)
- A model for optimizing delivery of targeted radionuclide therapies into resection cavity margins for the treatment of primary brain cancers (Q47400332) (← links)
- Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications (Q47589446) (← links)